C. Wamberg

Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

Marie Norsker Folke, B. Jespersen, D. Kondziella, 2021, Journal of Neurology.

Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

Marie Norsker Folke, B. Jespersen, D. Kondziella, 2020, Journal of Neurology.

Effects of truncated angiotensins in humans after double blockade of the renin system.

J. Simonsen, P. Høilund-Carlsen, N. Holstein-Rathlou, 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

F. Kapadia, J. Divatia, S. Myatra, 2022, Intensive Care Medicine.

Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs.

P. Bie, N. Sandgaard, R. Plovsing, 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

Developmental neurotoxicity study of the brominated flame retardant tetrabromobisphenol A in rats

U. Hass, C. Wamberg, 2002 .

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.

F. Kapadia, V. Jha, J. Divatia, 2021, JAMA.

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

F. Kapadia, V. Jha, J. Divatia, 2021, medRxiv.

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

F. Kapadia, V. Jha, J. Divatia, 2021, Intensive Care Medicine.

Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial

J. Divatia, S. Myatra, A. S. Andreasen, 2023, The Lancet regional health. Southeast Asia.

Risk of prolonged sedation with the use of chlordiazepoxide in alcohol withdrawal treatment

K. Dalhoff, T. Petersen, C. Wamberg, 2023, Adverse Drug Reaction Bulletin.